Discounted Cash Flow Rating

Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Sell

Wall Street Data Solutions Rating

Neutral

B

Janux Therapeutics, Inc. Common Stock (JANX)

Pharmaceutical Preparations

https://www.januxrx.com

Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.

10955 VISTA SORRENTO PARKWAY, SUITE 200
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/11/2021

Market Cap

2,145,004,240

Shares Outstanding

46,170,000

Weighted SO

46,168,430

Total Employees

N/A

Upcoming Earnings

N/A

Beta

3.5700

Last Div

0.0000

Range

5.65-65.6

Chg

-0.4000

Avg Vol

716756

Mkt Cap

2145004240

Exch

NASDAQ

Country

US

Phone

858 750 4700

DCF Diff

42.4735

DCF

-1.1435

Div Yield

0.0000

P/S

141.7997

EV Multiple

-33.4684

P/FV

3.4045

Div Yield %

0.0000

P/E

-50.8356

PEG

-2.1665

Payout

0.0000

Current Ratio

57.3356

Quick Ratio

57.3356

Cash Ratio

1.2700

DSO

290.8997

DIO

0.0002

Op Cycle

290.8999

DPO

221.0464

CCC

69.8535

Gross Margin

0.8632

Op Margin

-4.3586

Pretax Margin

-2.9117

Net Margin

-2.9117

Eff Tax Rate

-0.0214

ROA

-0.0637

ROE

-0.0878

ROCE

-0.0970

NI/EBT

1.0000

EBT/EBIT

0.6680

EBIT/Rev

-4.3586

Debt Ratio

0.0345

D/E

0.0362

LT Debt/Cap

0.0326

Total Debt/Cap

0.0350

Int Coverage

-20.1322

CF/Debt

-1.9508

Equity Multi

1.0513

Rec Turnover

1.2547

Pay Turnover

1.6512

Inv Turnover

999999.9999

FA Turnover

0.5814

Asset Turnover

0.0219

OCF/Share

-0.8534

FCF/Share

-0.8768

Cash/Share

11.8691

OCF/Sales

-3.0719

FCF/OCF

1.0275

CF Coverage

-1.9508

ST Coverage

-28.5080

CapEx Coverage

-36.3884

Div&CapEx Cov

-36.3884

P/BV

3.4045

P/B

3.4045

P/S

141.7997

P/E

-50.8356

P/FCF

-44.9263

P/OCF

-48.1848

P/CF

-48.1848

PEG

-2.1665

P/S

141.7997

EV Multiple

-33.4684

P/FV

3.4045

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation